Additionally, FBP1 binds to STAT3, blocks the binding of STAT3 to STAT3-mediated gene promoters, inhibits glycolysis in ovarian cancer cells, and improves cisplatin resistance in ovarian cancer [22]. This evidence concerns the gene FBP1 and ovarian carcinoma.